Skip to main content

Advertisement

SpringerLink
Log in

Probiotics in infectious diarrhoea in children: are they indicated?

  • Review
  • Published:
European Journal of Pediatrics Aims and scope Submit manuscript

An Erratum to this article was published on 09 October 2007

Abstract

Infectious gastroenteritis continues to be a leading cause of mortality and morbidity worldwide. The cornerstone of treatment remains replacement of water and electrolyte losses with oral rehydration solution. Until a few years ago, probiotics were discussed primarily in the context of alternative medicine, but they are now entering mainstream medical practice since a decrease of the severity and duration of infectious gastroenteritis in approximately 24 hours has been shown for some strains. Therefore, probiotics are a potential add-on therapy in acute gastro-enteritis. The shortening of the duration of diarrhoea and the reduction in hospital stay result in a social and economic benefit. Evidence found in viral gastroenteritis is more convincing than in bacterial or parasitic infection. Mechanisms of action are strain specific and only those commercial products for which there is evidence of clinical efficacy should be recommended. Timing of administration is also of importance. In acute gastroenteritis, there is evidence for efficacy of some strains of lactobacilli (e.g. Lactobacillus caseii GG and Lactobacillus reuteri) and for Saccharomyces boulardii. Probiotics are “generally regarded as safe”, but side effects such as septicaemia and fungaemia have very rarely been reported in high-risk situations. Although most studies conclude in a statistically significant shortening of the duration of diarrhea, the clinical relevance of this finding is limited. In conclusion, selected strains of probiotics result in a statistically significant but clinically moderate benefit in shortening the duration of diarrhoea caused by acute infectious gastroenteritis.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Agostoni C, Axelsson I, Braegger C, Goulet O, Koletzko B, Michaelsen KF, Rigo J, Shamir R, Szajewska H, Turck D, Weaver LT, ESPGHAN Committee on Nutrition (2004) Probiotic bacteria in dietetic products for infants: A commentary by the ESPGHAN Committee on Nutrition. J Pediatr Gastroenterol Nutr 38:365–374

    Article  PubMed  Google Scholar 

  2. Alam S, Bhatnagar S (2006) Current status of anti-diarrheal and anti-secretory drugs in the management of acute childhood diarrhea. Indian J Pediatr 73:693–696

    PubMed  Google Scholar 

  3. Allen SJ, Okoko B, Martinez E, Gregorio G, Dans LF (2004) Probiotics for treating infectious diarrhea. Cochrane Database Syst Rev 2:CD003048

    Google Scholar 

  4. Bernet MF, Brassart D, Neeser JR, Servin AL (1994) Lactobacillus acidophilus LA 1 binds to cultured human intestinal cell lines and inhibits cell attachment and cell invasion by enterovirulent bacteria. Gut 35:483–488

    Article  PubMed  CAS  Google Scholar 

  5. Billoo AG, Memon MA, Khaskheli SA, Murtaza G, Iqbal K, Saeed Shekhani M, Siddiqi A (2006) Role of a probiotics (Saccharomyces boulardii) in the management and prevention of diarrhea. World J Gastroenterol 12:4557–4560

    PubMed  CAS  Google Scholar 

  6. Borriello SP, Hammes WP, Holzapfel W, Marteau P, Schrezenmeir J, Vaara M, Valtonen V (2003) Safety of probiotics that contain Lactobacilli or Bifidobacteria. Clin Infect Dis 36:775–780

    Article  PubMed  CAS  Google Scholar 

  7. Bruzesse E (2006) Early administration of GOS/FOS prevents intestinal and respiratory infections in infants. J Pediatr Gastroenterol Nutr 42:E1–E110

    Article  Google Scholar 

  8. Buts JP, De Keyser N (2006) Effects of Saccharomyces boulardii on intestinal mucosa. Dig Dis Sci 51:1485–1492

    Article  PubMed  Google Scholar 

  9. Cabana MD, Shane AL, Chao C, Oliva-Henker M (2006) Probiotics in primary care pediatrics. Clin Pediatr 45:405–410

    Article  Google Scholar 

  10. Casburn-Jones AC, Farthing MJ (2004) Management of infectious diarrhoea. Gut 53:296–305

    Article  PubMed  CAS  Google Scholar 

  11. Cassone M, Serra P, Mondello F, Girolamo A, Scafetti S, Pistella E, Venstaditti M (2003) Outbreak of S. cerevisiae subtype boulardii fungemia in patients neighboring those treated with a probiotic preparation of the organism. Clin Microbiol 41:5340–5343

    Article  Google Scholar 

  12. Castañeda C, Garcia E, Santa Cruz M, Fernandez M, Monterrey P (1995) Effects of Saccharomyces boulardii in children with chronic diarrhea, especially cases due to giardiasis. Revista Mexicana de Puericultura y Pediatria 2:12–16

    Google Scholar 

  13. Cetina-Sauri G, Sierra Basto G (1994) Therapeutic evaluation of Saccharomyces boulardii in children with acute diarrhea. Ann Pediatr 41:397–400

    Google Scholar 

  14. Chouraqui JP, Van Egroo LD, Fichot MC (2004) Acidified milk formula supplemented with Bifidobacterium lactis: impact on infant diarrhea in residual care settings. J Pediatr Gatsroenterol Nutr 38:288–292

    Article  Google Scholar 

  15. Coconnier MH, Lievin V, Bernet-Camard MF, Hudault S, Servin AL (1997) Antibacterial effect of the adhering human Lactobacillus acidophilus strain LB. Antimicrob Agents Chemother 41:1046–1052

    PubMed  CAS  Google Scholar 

  16. Costa-Ribeiro H, Ribeiro TC, Mattos AP, Valois SS, Neri DA, Almeida P, Cerqueira CM, Ramos E, Young RJ, Vanderhoof JA (2003) Limitations of probiotic therapy in acute, severe dehydrating diarrhea. J Pediatr Gastroenterol Nutr 36:112–115

    Article  PubMed  Google Scholar 

  17. De Preter V, Vanhoutte T, Huys G, Swings J, Rutgeerts P, Verbeke K (2006) Effect of lactulose and Saccharomyces boulardii administration on the colonic urea-nitrogen metabolism and the bifidobacteria concentration in healthy human subjects. Aliment Pharmacol Ther 23:963–974

    Article  PubMed  CAS  Google Scholar 

  18. De Preter V, Vanhoutte T, Huys G, Swings J, De Vuyst L, Rutgeerts P, Verbeke K (2006) Effects of Lactobacillus casei Shirota, Bifidobacterium breve, and oligofructose-enriched inulin on the colonic nitrogen-protein metabolism in healthy humans. Am J Physiol Gastrointest Liver Physiol 292:G358–G368

    Article  PubMed  CAS  Google Scholar 

  19. Duggan C, Gannon J, Waker WA (2002) Protective nutrients and functional foods for the gastrointestinal tract. Am J Clin Nutr 75:789–808

    PubMed  CAS  Google Scholar 

  20. Elliott E, Teversham K (2004) An evaluation of nine probiotics available in South Africa, August 2003. SAMJ 94:121–124

    Google Scholar 

  21. Enache-Angoulvant A (2005) Invasive Saccharomyces infection: a comprehensive review. Clin Infect Dis 41:1559–1568

    Article  PubMed  Google Scholar 

  22. Fedorak RN, Madsen KI (2004) Probiotics and prebiotics in gastrointestinal disorders. Curr Opin Gastroenterol 20:146–155

    Article  PubMed  Google Scholar 

  23. Guandalini S, Pensabene L, Zikri MA, Dias JA, Casali LG, Hoekstra H, Kolacek S, Massar K, Micetic-Turk D, Papadopoulou A, de Sousa JS, Sandhu B, Szajewska H, Weizman Z (2000) Lactobacillus GG administered in oral rehydration solution in children with acute diarrhea: a multicenter European trial. J Pediatr Gastroenterol Nutr 30:214–216

    Article  Google Scholar 

  24. Guarino A, Berni Canani R, Spagnuolo MI, Bisceglia M, Boccia MC, Rubino A (1997) Oral bacterial therapy reduces the duration of symptoms and viral excretion in children with mild diarrhea. J Pediatr Gastroenterol Nutr 25:516–519

    Article  PubMed  CAS  Google Scholar 

  25. Hilton E, Kolakowski P, Singer C, Smith M (1997) Efficacy of Lactobacillus GG as a diarrheal preventive in travelers. J Travel Med 4:41–43

    Article  PubMed  Google Scholar 

  26. Höchter W, Chase D, Hagenhoff G (1990) Saccharomyces boulardii bei akuter Erwachsenendiarrhoe. Münch Med Wschr 132:188–192

    Google Scholar 

  27. Huang JS, Bousvaros A, Lee JW, Diaz A, Davidson EJ (2002) Efficacy of probiotic use in acute diarrhea in children: a meta-analysis. Dig Dis Sci 47:2625–2634

    Article  PubMed  CAS  Google Scholar 

  28. Ibnou-Zekri N, Blum S, Schiffrin EJ, von der Weid T (2003) Divergent patterns of colonization and immune response elicited from two intestinal Lactobacillus strains that display similar properties in vitro. Infect Immun 71:428–436

    Article  PubMed  CAS  Google Scholar 

  29. Isolauri E, Juntunen M, Rautanen T, Sillanaukee P, Koivula T (1991) A human Lactobacillus strain (Lactobacillus casei sp strain GG) promotes recovery from acute diarrhea in children. Pediatrics 88:90–97

    PubMed  CAS  Google Scholar 

  30. Jijon H, Backer J, Diaz H, Yeung H, Thiel D, McKaigney C, De Simone C, Madsen K (2004) DNA from probiotic bacteria modulates murine and human epithelial and immune function. Gastroenterology 126:1358–1373

    Article  PubMed  CAS  Google Scholar 

  31. Juntunen M, Kirjavainen PV, Ouwehand AC, Salminen SJ, Isolauri E (2001) Adherence of probiotic bacteria to human intestinal mucus in healthy infants and during rotavirus infection. Clin Diagn Lab Immunol 8:293–296

    Article  PubMed  CAS  Google Scholar 

  32. Katelaris PH, Salam I, Farthing MJ (1995) Unspecified Lactobacillus acidophilus in prevention traveler’s diarrhea. N Eng J Med 333:1360–1361

    Article  CAS  Google Scholar 

  33. Khanna V, Alam S, Malik A (2005) Efficacy of tyndalized Lactobacillus acidophilus in acute diarrhea. Indian J Pediatr 72:935–938

    Article  PubMed  Google Scholar 

  34. Kollaritsch H (1989) Traveller’s diarrhea among Austrian tourists to warm climate countries: II. Clinical features. Eur J Epidemiol 5:355–362

    Article  PubMed  CAS  Google Scholar 

  35. Kowalska-Duplaga K, Fyderek K, Szajewska H, Janiak R (2004) Efficacy of Trilac® in the treatment of acute diarrhoea in infants and young children - a multicentre, randomized, double-blind placebo-controlled study. Pediatria Współczesna 3:295–299

    Google Scholar 

  36. Kurugol Z, Koturoglu G (2005) Effects of Saccharomyces boulardii in children with acute diarrhoea. Acta Paediatr 94:44–47

    Article  PubMed  CAS  Google Scholar 

  37. Land MH, Rouster-Steven K, Woods Dr (2005) Lactobacillus sepsis associated with probiotic therapy. Pediatrics 115:178–181

    PubMed  Google Scholar 

  38. Lilly DM, Stillwell RH (1965) Probiotic growth promoting factors produced by microorganisms. Science 147:747–748

    Article  PubMed  CAS  Google Scholar 

  39. Mackay AD, Taylor MB, Kibbler CC, Hamilton-Miller JM (1999) Lactobacillus endocarditis caused by a probiotics organism. Clin Microbiol Infect 5:290–292

    Article  PubMed  Google Scholar 

  40. Mansour-Ghanaei F, Dehbashi N, Yazdanparast K, Shafaghi A (2003) Efficacy of Saccharomyces boulardii with antibiotics in acute amoebiasis. World J Gastroenterol 9:1832–1833

    PubMed  Google Scholar 

  41. Marteau P, Pochart P, Bouhnik Y, Zidi S, Goderel I, Rambaud JC (1992) Survival of Lactobacillus acidophilus and Bifidobacterium sp. in the small intestine following ingestion in fermented milk. A rational basis for the use of probiotics in man. Gastroenterol Clin Biol 16:25–28

    PubMed  CAS  Google Scholar 

  42. Mastretta E, Longo P, Laccisaglia A, Balbo L, Russo R, Mazzaccara A, Gianino P (2002) Effect of a Lactobacillus GG and breast-feeding in the prevention of rotavirus nosocomial infection. J Pediatr Gastroenterol Nutr 35:527–531

    Article  PubMed  Google Scholar 

  43. Michail S, Abernathy F (2002) Lactobacillus plantarum reduces the in vitro secretory response of intestinal epithelial cells in enteropathogenic Escherichia coli infection. J Pediatr Gastroenterol Nutr 35:350–355

    Article  PubMed  CAS  Google Scholar 

  44. NASPGHAN Nutrition Report Committee; Michail S, Sylvester F, Fuchs G, Issenman R (2006) Clinical efficacy of probiotics: review of the evidence with focus on children. J Pediatr Gastroenterol Nutr 43:550–557

    Article  PubMed  Google Scholar 

  45. Oksanen PJ, Salminen S, Saxelin M, Hamalainen P, Ihantola-Vormisto A, Muurasniemi-Isoviita L, Nikkari S, Oksanen T, Porsti I, Salminen E, et al (1990) Prevention of travellers’ diarrhoea by Lactobacillus GG. Ann Med 22:53–56

    PubMed  CAS  Google Scholar 

  46. Rautio M, Jousimies-Somer H, Kauma H, Pietarinen I, Saxelin M, Tynkkynen S, Koskela M (1999) Liver abcess due to a Lactobacillus rhamnosus strain indistinguishable from a L. rhamnosus strain GG. Clin Infect Dis 28:1159–1160

    PubMed  CAS  Google Scholar 

  47. Raza S, Graham SM, Allen SJ (1995) Lactobacillus GG promotes recovery from acute nonbloody diarrhea in Pakistan. Pediatr Infect Dis J 14:107–111

    Article  PubMed  CAS  Google Scholar 

  48. Saavedra JM, Bauman NA, Oung I, Perman JA, Yolken RH (1994) Feeding of Bifidobacterium bifidum and Streptococcus thermophilus to infants in hospital for prevention of diarrhoea and shedding of rotavirus. Lancet 344:1046–1049

    Article  PubMed  CAS  Google Scholar 

  49. Saint-Marc T, Rossello-Prats L, Touraine JL (1991) Efficacy of Saccharomyces boulardii in the treatment of diarrhea in AIDS. Ann Med Interne (Paris) 142:64–65

    CAS  Google Scholar 

  50. Salazar-Lindo E, Miranda-Langschwager P, Campos-Sanchez M, Chea-Woo E, Sack RB (2004) Lactobacillus casei strain GG in the treatment of infants with acute watery diarrhea: A randomized, double-blind, placebo controlled clinical trial [ISRCTN67363048]. BMC Pediatr 4:18

    Article  PubMed  Google Scholar 

  51. Saran S, Gopalan S, Krishna TP (2002) Use of fermented foods to combat stunting and failure to thrive. Nutrition 18:393–396

    Article  PubMed  Google Scholar 

  52. Sarker SA, Sultana S, Fuchs GJ, Alam NH, Azim T, Brussow H, Hammarstrom L (2005) Lactobacillus paracasei strain ST11 has no effect on rotavirus but ameliorates the outcome of nonrotavirus diarrhea in children from Bangladesh. Pediatrics 116:e221–e228

    Article  PubMed  Google Scholar 

  53. Sazawal S, Hiremath G, Dhingra U, Malik P, Deb S, Black RE (2006) Efficacy of probiotics in prevention of acute diarrhoea: a meta-analysis of masked, randomised, placebo-controlled trials. Lancet Infect Dis 6:374–382

    Article  PubMed  Google Scholar 

  54. Shamir R, Makhoul IR, Etzioni A, Shehadeh N (2005) Evaluation of a diet containing probiotics and zinc for the treatment of mild diarrheal illness in children younger than one year of age. J Am Coll Nutr 24:370–375

    PubMed  CAS  Google Scholar 

  55. Shornikova AV, Isolauri E, Burkanova L, Lukovnikova S, Vesikari T (1997) A trial in the Karelian Republic of oral rehydration and Lactobacillus GG for treatment of acute diarrhoea. Acta Paediatr 86:460–465

    PubMed  CAS  Google Scholar 

  56. Shornikova AV, Casas IA, Mykkanen H, Salo E, Vesikari T (1997) Bacteriotherapy with Lactobacillus reuteri in rotavirus gastroenteritis. Pediatr Infect Dis J 16:1103–1107

    Article  PubMed  CAS  Google Scholar 

  57. Simakachorn N, Pichaipat V, Rithipornpaisarn P, Kongkaew C, Tongpradit P, Varavithya W (2000) Clinical evaluation of the addition of lyophilized, heat-killed Lactobacillus acidophilus LB to oral rehydration therapy in the treatment of acute diarrhea in children. J Pediatr Gastroenterol Nutr 30:68–72

    Article  PubMed  CAS  Google Scholar 

  58. Sougioultzis S, Simeonidis S, Bhaskar KR, Chen X, Anton PM, Keates S, Pothoulakis C, Kelly CP (2006) Saccharomyces boulardii produces a soluble anti-inflammatory factor that inhibits NF-kappaB-mediated IL-8 gene expression. Biochem Biophys Res Commun 343:69–76

    Article  PubMed  CAS  Google Scholar 

  59. Szajewska H, Kotowska M, Mrukowicz JZ, Armanska M, Mikolajczyk W (2001) Efficacy of Lactobacillus GG in prevention of nosocomial diarrhea in infants. J Pediatr 138:361–365

    Article  PubMed  CAS  Google Scholar 

  60. Szajewska H, Mrukowicz JZ (2005) Use of probiotics in children with acute diarrhea. Paediatr Drugs 7:111–122

    Article  PubMed  Google Scholar 

  61. Szajewska H, Setty M, Mrukowicz J, Guandalini S (2006) Probiotics in gastrointestinal disease in children: hard and not-so-hard evidence of efficacy. J Pediatr Gastroenterol Nutr 42:454–475

    Article  PubMed  Google Scholar 

  62. Szajewska H, Mrukowicz JZ (2001) Probiotics in the treatment and prevention of acute infectious diarrhea in infants and children: a systematic review of published randomized, double-blind, placebo-controlled trials. J Pediatr Gastroenterol Nutr 33:S17–S25

    Article  PubMed  CAS  Google Scholar 

  63. Szajewska H, Skorka A, Dylag M (2007) Meta-analysis: Saccharomyces boulardii for treating acute diarrhoea in children. Aliment Pharmacol Ther 25;257–64

    Article  PubMed  CAS  Google Scholar 

  64. Szymanski H, Pejcz J, Jawien M, Chmielarczyk A, Strus M, Heczko PB (2006) Treatment of acute infectious diarrhoea in infants and children with a mixture of three Lactobacillus rhamnosus strains-a randomized, double-blind, placebo-controlled trial. Aliment Pharmacol Ther 23:247–253

    Article  PubMed  CAS  Google Scholar 

  65. Szymanski H, Chmielarczyk A, Strus M, Pejcz J, Jawien M, Kochan P, Heczko PB (2006) Colonisation of the gastrointestinal tract by probiotic L. rhamnosus strains in acute diarrhoea in children. Dig Liver Dis 38(Suppl 2):S274–S276

    Article  PubMed  Google Scholar 

  66. Temmerman R, Pot B, Huys G, Swings J (2003) Identification and antibiotic susceptibility of bacterial isolates from probiotic products. Int J Food Microbiol 81:1–10

    Article  PubMed  CAS  Google Scholar 

  67. Thibault H, Aubert-Jacquin C, Goulet O (2004) Effects of long-term consumption of a fermented infant formula (with Bifidoacterium breve c50 and Streptococcus thermophilus 065) on acute diarrheda in healthy infants. J Pediatr Gastroenterol Nutr 39:147–152

    Article  PubMed  CAS  Google Scholar 

  68. Tissier H (1906) Traitement des infections intestinales par la méthode de la transformation de la flore bactérienne de l’intestin. C R Soc Biol 60:359–361

    Google Scholar 

  69. Van Niel CW, Feudtner C, Garrison MM, Christakis DA (2002) Lactobacillus therapy for acute infectious diarrhea in children: a meta-analysis. Pediatrics 109:678–84

    Article  PubMed  Google Scholar 

  70. Villarruel G, Rubio DM, Lopez F, Cintioni J, Gurevech R, Romero G, Vandenplas Y (2007) Saccharomyces boulardii in acute childhood diarrhea: a randomized, placebo-controlled study. Acta Paediatr (in press)

Download references

Author information

Authors and Affiliations

  1. Universitair Ziekenhuis Brussel Junior, Vrije Universiteit Brussel, Laarbeeklaan 101, 1090, Brussels, Belgium

    Y. Vandenplas, T. Devreker & B. Hauser

  2. Clinica Pediatrica di Varese, Università dell’Insubria, Varese, Italy

    S. Salvatore

  3. Hospital Pequeno Príncipe, Curitiba, Brazil

    M. Viera

Authors
  1. Y. Vandenplas
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. S. Salvatore
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. M. Viera
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. T. Devreker
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. B. Hauser
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Y. Vandenplas.

Additional information

An erratum to this article can be found at http://dx.doi.org/10.1007/s00431-007-0585-x

Rights and permissions

Reprints and permissions

About this article

Cite this article

Vandenplas, Y., Salvatore, S., Viera, M. et al. Probiotics in infectious diarrhoea in children: are they indicated?. Eur J Pediatr 166, 1211–1218 (2007). https://doi.org/10.1007/s00431-007-0497-9

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00431-007-0497-9

Keywords

Search

Navigation